| caffeic acid |
| 3,4-Dihydroxycinnamic acid |
| 331-39-5 |
| trans-caffeic acid |
| 501-16-6 |
| 3-(3,4-dihydroxyphenyl)acrylic acid |
| 3,4-Dihydroxybenzeneacrylic acid |
| (E)-3-(3,4-dihydroxyphenyl)acrylic acid |
| (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid |
| 3-(3,4-Dihydroxyphenyl)-2-propenoic acid |
| (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid |
| Caffeicacid |
| Cinnamic acid, 3,4-dihydroxy- |
| 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)- |
| 4-(2-Carboxyethenyl)-1,2-dihydroxybenzene |
| trans-Caffeate |
| CCRIS 847 |
| NSC 57197 |
| 3,4-Dihydroxy-trans-cinnamate |
| 3-(3,4-Dihydroxyphenyl)propenoic acid |
| (E)-3,4-dihydroxycinnamic acid |
| HSDB 7088 |
| UNII-U2S3A33KVM |
| 4-(2'-Carboxyvinyl)-1,2-dihydroxybenzene |
| 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (E)- |
| 71693-97-5 |
| EINECS 206-361-2 |
| U2S3A33KVM |
| NSC-57197 |
| Caffeate |
| NSC-623438 |
| CHEBI:16433 |
| AI3-63211 |
| trans-3,4-Dihydroxycinnamic Acid |
| 3-(3,4-Dihydroxy phenyl)-2-propenoic acid |
| NSC57197 |
| 331-89-5 |
| CHEMBL145 |
| 3-(3,4-dihydroxyphenyl)prop-2-enoic acid |
| MLS000069738 |
| CHEBI:36281 |
| MFCD00004392 |
| NSC623438 |
| 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (2E)- |
| SMR000058214 |
| (2E)-3-(3,4-dihydroxyphenyl)acrylic acid |
| CAFFEIC ACID (IARC) |
| CAFFEIC ACID [IARC] |
| Caffeic acid - Natural |
| SR-01000000203 |
| caffeic acid, (E)-isomer |
| DTXSID5020231 |
| caffeic-acid |
| Caffeic acid pure |
| Caffeic acid, 1 |
| Caffeic acid 1000 microg/mL in Acetone |
| 3,4-dihydroxycinnamic acid (caffeic acid) |
| Caffeic Acid,(S) |
| Caffeic Acid1507 |
| Caffeic acid, trans- |
| 3,4-dihydroxycinnamate |
| CAFFEIC ACID natural |
| Opera_ID_1700 |
| CAFFEIC ACID [MI] |
| CAFFEIC ACID [DSC] |
| Cinnamic acid,4-dihydroxy- |
| 3,4-Dihydroxycinnamic acid, predominantly trans |
| CAFFEIC ACID [HSDB] |
| CAFFEIC ACID [INCI] |
| 3,4-Dihydroxybenzeneacrylate |
| SCHEMBL23358 |
| MLS001076493 |
| MLS002207132 |
| MLS002222302 |
| MLS006011849 |
| BIDD:ER0456 |
| DTXCID10231 |
| SPECTRUM1503987 |
| CAFFEIC ACID [WHO-DD] |
| 2-Propenoic acid,3-(3,4-dihydroxyphenyl)-, (2E)- |
| 3,4-Dihydroxycinnamate, XVII |
| BDBM4375 |
| cid_689043 |
| GTPL5155 |
| AMY3943 |
| Trans 3,4-Dihydroxycinnamic acid |
| DTXSID901316055 |
| HMS2235G09 |
| HMS3260J17 |
| HMS3649O17 |
| BCP28271 |
| HY-N0172 |
| Tox21_200648 |
| Tox21_500208 |
| BBL012113 |
| Caffeic Acid - CAS 331-39-5 |
| CCG-38895 |
| s2277 |
| STK397812 |
| Caffeic acid, >=98.0% (HPLC) |
| 2-Propenoic acid,4-dihydroxyphenyl)- |
| AKOS000144463 |
| AC-8006 |
| CS-8205 |
| DB01880 |
| LP00208 |
| SDCCGMLS-0002982.P003 |
| SDCCGSBI-0050196.P004 |
| NCGC00017364-04 |
| NCGC00017364-05 |
| NCGC00017364-06 |
| NCGC00017364-07 |
| NCGC00017364-08 |
| NCGC00017364-09 |
| NCGC00017364-10 |
| NCGC00017364-11 |
| NCGC00017364-12 |
| NCGC00017364-13 |
| NCGC00017364-22 |
| NCGC00022654-03 |
| NCGC00022654-04 |
| NCGC00022654-05 |
| NCGC00022654-06 |
| NCGC00022654-07 |
| NCGC00022654-08 |
| NCGC00022654-09 |
| NCGC00258202-01 |
| NCGC00260893-01 |
| NCGC00263641-01 |
| (E)-3-(3,4-dihydroxyphenyl)acrylicacid |
| AS-10895 |
| BP-30112 |
| CAS-331-39-5 |
| SMR004703501 |
| XC164210 |
| 4-(2'Carboxyvinyl)-1,2-dihydroxybenzene |
| Caffeic acid, purum, >=95.0% (HPLC) |
| DB-318886 |
| DB-321780 |
| HY-121231 |
| AB00490047 |
| CS-0081280 |
| EU-0100208 |
| NS00010313 |
| SW197202-3 |
| 2-Morpholin-4-yl-isonicotinicacidhydrochloride |
| 2-Propenoic acid, 3-(3,4-dihdroxyphenyl)- |
| (E)-3-(3,4-dihydroxyphenyl)prop-2-enoicacid |
| C 0625 |
| C-1500 |
| C01197 |
| C01481 |
| EN300-1067793 |
| (2E)-3-(3,4-Dihydroxyphenyl)-2-propenoic acid |
| A851723 |
| CAFFEIC ACID (CONSTITUENT OF BLACK COHOSH) |
| Q414116 |
| SR-01000000203-2 |
| SR-01000000203-6 |
| SR-01000000203-7 |
| SR-01000000203-8 |
| BRD-K09900591-001-06-9 |
| SR-01000000203-13 |
| CAFFEIC ACID (CONSTITUENT OF BLACK COHOSH) [DSC] |
| F3096-1708 |
| Z240113804 |
| 2',3-DIHYDROXY-4,4',6'-TRIMETHOXYCHALCONE_met021 |
| 2',4-DIHYDROXY-3,4',6'-TRIMETHOXYCHALCONE_met023 |
| 8B3E4DA7-F3B0-4972-A315-2E387071737F |
| trans-Caffeic acid, certified reference material, TraceCERT(R) |
| Caffeic acid, matrix substance for MALDI-MS, >=99.0% (HPLC) |
| Caffeic acid, United States Pharmacopeia (USP) Reference Standard |
| Caffeic acid, matrix substance for MALDI-MS, >=99.0% (HPLC), powder, light beige |
| InChI=1/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2 |